Updated July 31 at 5:31pm
Biotechnology
30 results total, viewing 1 - 10
The first two patients in IlluminOss Medical Inc.’s U.S. Lightfix clinical trial for the treatment of impending and pathologic fractures have been successfully treated at the Marshall University Joan C. Edwards School of Medicine. more
The Defense Threat Reduction Agency is investing $5.2 million for the development of a new type of vaccine against Q fever, and a local company is involved in the effort. more
ProThera Biologics has appointed Denice M. Spero as president and chief business officer. more
Medrobotics Corp. was named a “rising star” in the Smaller Business Association of New England Inc.’s 2015 New England Innovation Awards. more
Amy Orlick Berman has been appointed IlluminOss Medical’s vice president of clinical affairs. more
Brown University has leased its 4,000-square-foot building at 349 Eddy St. to biotechnology firm ProThera Biologics. more
At a state-of-the-art facility in Thousand Oaks, Calif., drugmaker Amgen Inc. is perfecting the art of copying others. more
Mallinckrodt Plc agreed to acquire Ikaria Inc. for about $2.3 billion from a group of investors led by Madison Dearborn Partners and including New Mountain Capital LLC to expand in neonatal intensive care treatments. more
Big Brothers Big Sisters of the Ocean State recently received a $30,000 Amgen Foundation Grant to develop and implement a Science, Technology, Engineering and Mathematics curriculum into the mentoring agency’s site-based programming. more
The U.S. Treasury Department has released $4.3 million, the second tranche of a $13.1 million State Small Business Credit Initiative grant awarded to Rhode Island four years ago, to support the Slater Technology Fund’s SSBCI program. more
1 | 2 | 3 Next »